IP Verse

Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions

Patent No. EP3085780 (titled "Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions") was filed by Regeneron Pharmaceuticals on Feb 15, 2002. The application was issued on Jun 28, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KYMABJun 28, 2019CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3085780

REGENERON PHARMACEUTICALS
Application Number
EP16171561A
Filing Date
Feb 15, 2002
Status
Patent Maintained As Amended
May 26, 2023
Publication Date
Jun 28, 2023
External Links
Slate, Register , Google Patents